drugset / Trial / NCT01846481

A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse

NCT01846481

Phase 2 Completed 40 enrolled Indivior Inc.
RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a randomized, 4-sequence, 2-period, double-blind, placebo controlled study in male and female subjects with an American Psychiatric Association Diagnostic and Statistical Manual DSM-IV-TR diagnosis of cocaine abuse.

Timeline

Start
2013-04
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cocaine Small molecule 50 mg Intravenous
Subject RBP-8000 Unknown 100 mg Intravenous
Subject RBP-8000 Unknown 200 mg Intravenous